These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 15709170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.
    Takahashi O, Hamada J, Abe M, Hata S, Asano T, Takahashi Y, Tada M, Miyamoto M, Kondo S, Moriuchi T.
    Oncol Rep; 2007 Apr; 17(4):753-60. PubMed ID: 17342311
    [Abstract] [Full Text] [Related]

  • 4. [Expression of 39 HOX genes in esophageal cancer cell lines].
    Gu ZD, Chen XM, Zhang W, Gu J, Chen KN.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):365-7. PubMed ID: 17659465
    [Abstract] [Full Text] [Related]

  • 5. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A, Faried LS, Usman N, Kato H, Kuwano H.
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [Abstract] [Full Text] [Related]

  • 6. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
    Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y, Liu Z.
    Clin Cancer Res; 2006 Mar 01; 12(5):1639-46. PubMed ID: 16533792
    [Abstract] [Full Text] [Related]

  • 7. Loss of MAL expression in precancerous lesions of the esophagus.
    Mimori K, Nishida K, Nakamura Y, Ieta K, Yoshikawa Y, Sasaki A, Ishii H, Alonso MA, Mori M.
    Ann Surg Oncol; 2007 May 01; 14(5):1670-7. PubMed ID: 17151798
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, Shimada Y.
    Clin Cancer Res; 2005 Apr 01; 11(7):2597-605. PubMed ID: 15814639
    [Abstract] [Full Text] [Related]

  • 10. [Expression and significance of MCM4 in esophageal cancer].
    Huang XP, Zhang X, Su XD, Ma GW, Zhao JM, Rong TH.
    Ai Zheng; 2007 Jan 01; 26(1):96-9. PubMed ID: 17222376
    [Abstract] [Full Text] [Related]

  • 11. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
    Qi YJ, Wang LD, Jiao XY, Feng XS, Fan ZM, Gao SS, He X, Li JL, Chang FB.
    Ai Zheng; 2007 Jul 01; 26(7):730-6. PubMed ID: 17626749
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Mori Y, Ogawa R, Katada T, Harata K, Fujii Y.
    Oncol Rep; 2008 Mar 01; 19(3):713-9. PubMed ID: 18288406
    [Abstract] [Full Text] [Related]

  • 13. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.
    Gu ZD, Shen LY, Wang H, Chen XM, Li Y, Ning T, Chen KN.
    Cancer Res; 2009 Jun 15; 69(12):4969-73. PubMed ID: 19491265
    [Abstract] [Full Text] [Related]

  • 14. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma.
    Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Yanaga K, Ohkawa K, Hashimoto N, Nakajima T, Saito H, Matsushima M, Urashima M.
    Cancer Res; 2003 Aug 15; 63(16):5159-64. PubMed ID: 12941848
    [Abstract] [Full Text] [Related]

  • 15. Comparative proteomic analysis of esophageal squamous cell carcinoma.
    Qi Y, Chiu JF, Wang L, Kwong DL, He QY.
    Proteomics; 2005 Jul 15; 5(11):2960-71. PubMed ID: 15986332
    [Abstract] [Full Text] [Related]

  • 16. The differential expression of SPARC in esophageal squamous cell carcinoma.
    Che Y, Luo A, Wang H, Qi J, Guo J, Liu Z.
    Int J Mol Med; 2006 Jun 15; 17(6):1027-33. PubMed ID: 16685412
    [Abstract] [Full Text] [Related]

  • 17. Disordered expression of HOX genes in human non-small cell lung cancer.
    Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T.
    Oncol Rep; 2006 Apr 15; 15(4):797-802. PubMed ID: 16525661
    [Abstract] [Full Text] [Related]

  • 18. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.
    Oncol Rep; 2007 Sep 15; 18(3):601-9. PubMed ID: 17671707
    [Abstract] [Full Text] [Related]

  • 19. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H.
    Ann Surg Oncol; 2009 Sep 15; 16(9):2494-501. PubMed ID: 19526206
    [Abstract] [Full Text] [Related]

  • 20. SEL1L and squamous cell carcinoma of the esophagus.
    Granelli P, Cattaneo M, Ferrero S, Bottiglieri L, Bosari S, Fichera G, Biunno I.
    Clin Cancer Res; 2004 Sep 01; 10(17):5857-61. PubMed ID: 15355917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.